ArticleFrontiers in pediatrics2026
Clinical spectrum and management outcomes of acute febrile illness Among children attending health facilities in northwestern Tanzania, 2020-2021.
Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The diagnostic challenges of febrile illness in children in low-resource settings and the risks of empirical overtreatment. We evaluated the range of clinical presentations and management outcomes in a cohort of children with acute febrile illness, building on our previous examination of the etiology of these illnesses. Methods: This prospective cohort study enrolled children aged 1 to ≤12 years who were cared for by attending clinicians across primary, secondary, and tertiary healthcare settings. Management decisions were based on clinical presentation and laboratory and radiographic findings available on the day of enrollment. Outcomes were measured on days 7, 14, and 28. The study also analyzed prescription patterns for antibiotics and antimalarials in relation to established guidelines. Results: In this cohort of 434 children with acute febrile illness, the most common initial diagnoses were acute respiratory infections (31.3%, 136/434), of which upper respiratory tract infection (URTI) was observed in 57.0% (77/136) and pneumonia in 43.0% (59/136), followed by malaria (23.7%, 103/434). Antibacterial agents were prescribed to 65.3% (284/434) of children. Antibiotic overprescription was observed in 29.6% (84/285) of study participants. Antimalarial drugs were prescribed to 38.9% (169/434) of patients, including 103 patients judged to have malaria by a positive MRDT or a positive blood smear. A total of 66 (39.0%) patients who received antimalarial drugs were negative for either MRDT or blood smear. Fever resolved in 398 children (96.0%, 386/402) by day 28 of follow-up. The most commonly documented complications among admitted children included anemia (36.0%), dehydration (9.1%), shock (8.5%), and acute kidney injury (8.5%). Overall mortality at day 28 was 1.0% (4/434). Conclusion: In environments with limited diagnostic resources, children with acute febrile illness are often treated empirically. This results in significant overprescription of antibiotics and antimalarials. While short-term results are usually positive, such practices raise concerns about antimicrobial resistance and adherence to guidelines. Better access to point-of-care diagnostics can help decrease inappropriate prescriptions and improve care quality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.